Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7551556

Concept As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-06-30
As at
2022-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
16,023,000,000 JPY
60,461,000,000 JPY
15,269,000,000 JPY
Ordinary profit (loss)
1,809,000,000 JPY
5,232,000,000 JPY
1,805,000,000 JPY
Net assets
56,881,000,000 JPY
54,533,000,000 JPY
50,477,000,000 JPY
Total assets
89,166,000,000 JPY
87,138,000,000 JPY
84,764,000,000 JPY
Basic earnings (loss) per share
50.51
150.08
46.94
Diluted earnings per share
Equity-to-asset ratio
0.638 xbrli:pure
0.626 xbrli:pure
0.596 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.